DK0581106T3 - Substituerede aminothienopyridiner, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler - Google Patents

Substituerede aminothienopyridiner, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler

Info

Publication number
DK0581106T3
DK0581106T3 DK93111209T DK93111209T DK0581106T3 DK 0581106 T3 DK0581106 T3 DK 0581106T3 DK 93111209 T DK93111209 T DK 93111209T DK 93111209 T DK93111209 T DK 93111209T DK 0581106 T3 DK0581106 T3 DK 0581106T3
Authority
DK
Denmark
Prior art keywords
preparation
aminothienopyridines
drugs
substituted
compounds
Prior art date
Application number
DK93111209T
Other languages
English (en)
Inventor
Richard Charles Effland
Joseph Thomas Klein
Lawrence Leo Martin
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DK0581106T3 publication Critical patent/DK0581106T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
DK93111209T 1992-07-20 1993-07-13 Substituerede aminothienopyridiner, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler DK0581106T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/917,247 US5252581A (en) 1992-07-20 1992-07-20 Substituted aminothienopyridines, pharmaceutical composition and use

Publications (1)

Publication Number Publication Date
DK0581106T3 true DK0581106T3 (da) 1999-02-15

Family

ID=25438534

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93111209T DK0581106T3 (da) 1992-07-20 1993-07-13 Substituerede aminothienopyridiner, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler

Country Status (13)

Country Link
US (3) US5252581A (da)
EP (1) EP0581106B1 (da)
JP (1) JP2757745B2 (da)
KR (1) KR100292212B1 (da)
AT (1) ATE166355T1 (da)
AU (1) AU662640B2 (da)
CA (1) CA2100812C (da)
DE (1) DE69318636T2 (da)
DK (1) DK0581106T3 (da)
ES (1) ES2116371T3 (da)
MX (1) MX9304353A (da)
NZ (1) NZ248170A (da)
TW (1) TW243450B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252581A (en) * 1992-07-20 1993-10-12 Hoechst-Roussel Pharmaceuticals Inc. Substituted aminothienopyridines, pharmaceutical composition and use
US5272148A (en) * 1992-09-09 1993-12-21 Hoechst-Roussel Pharmaceuticals Incorporated Heteroarenylpiperazines
EP0599697A1 (fr) * 1992-11-24 1994-06-01 Synthelabo Dérivés de pyrrole, leur préparation et leur application en thérapeutique
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists
US20060167114A1 (en) * 1998-03-09 2006-07-27 Louis Shuster Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors
US20070197651A1 (en) * 1998-03-09 2007-08-23 Tufts University Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors
WO1999045906A1 (en) 1998-03-09 1999-09-16 Trustees Of Tufts College Treatment of compulsive behaviours in man and animals
US6867203B2 (en) 1998-12-29 2005-03-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
US7875627B2 (en) 2004-12-07 2011-01-25 Abbott Laboratories Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
WO2007027855A2 (en) * 2005-09-01 2007-03-08 Array Biopharma Inc. Raf inhibitor compounds and methods of use thereof
JP2009529047A (ja) 2006-03-07 2009-08-13 アレイ バイオファーマ、インコーポレイテッド ヘテロ二環系ピラゾール化合物およびその使用
KR20120120416A (ko) 2010-02-11 2012-11-01 벤더르빌트 유니버시티 Mglur4 알로스테릭 강화제로서 벤즈이속사졸 및 아자벤즈이속사졸, 조성물, 및 신경 기능이상을 치료하는 방법
JP5102401B1 (ja) 2012-03-30 2012-12-19 森下仁丹株式会社 大腸特異崩壊性カプセル
US11466027B2 (en) 2019-07-03 2022-10-11 H. Lundbeck A/S Modulators of the NMDA receptor
US11358971B2 (en) 2019-07-03 2022-06-14 H. Lundbeck A/S Prodrugs of modulators of the NMDA receptor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US281152A (en) * 1883-07-10 Safety-pin
US2811527A (en) * 1955-11-16 1957-10-29 Olin Mathieson Derivatives of thieno (3, 2-b) pyridine and method of preparing same
NO140499C (no) * 1973-07-23 1979-09-12 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av thienopyridinkarboksylsyrederivcater med terapeutisk aktivitet
US3952989A (en) * 1974-11-26 1976-04-27 Bannister Hatcher Constance L Adjustable reading material stand
FR2440738A1 (fr) * 1978-11-13 1980-06-06 Parcor Medicament a base de derives des thieno (2,3-c) et (3,2-c) pyridines
US5026698A (en) * 1988-11-02 1991-06-25 Nissan Chemical Industries, Ltd. Thienopyridine type mevalonolactones
US5252581A (en) * 1992-07-20 1993-10-12 Hoechst-Roussel Pharmaceuticals Inc. Substituted aminothienopyridines, pharmaceutical composition and use

Also Published As

Publication number Publication date
EP0581106A1 (en) 1994-02-02
US5519032A (en) 1996-05-21
DE69318636T2 (de) 1998-11-26
TW243450B (da) 1995-03-21
US5252581A (en) 1993-10-12
AU662640B2 (en) 1995-09-07
DE69318636D1 (de) 1998-06-25
JP2757745B2 (ja) 1998-05-25
CA2100812C (en) 2006-11-14
CA2100812A1 (en) 1994-01-21
KR100292212B1 (ko) 2001-09-17
AU4200193A (en) 1994-01-27
ES2116371T3 (es) 1998-07-16
MX9304353A (es) 1994-02-28
KR940002249A (ko) 1994-02-17
NZ248170A (en) 1995-12-21
ATE166355T1 (de) 1998-06-15
JPH06179681A (ja) 1994-06-28
EP0581106B1 (en) 1998-05-20
US5856335A (en) 1999-01-05

Similar Documents

Publication Publication Date Title
DK0581106T3 (da) Substituerede aminothienopyridiner, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
DE69427704D1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane
GB0325956D0 (en) Novel compounds
DK0380063T3 (da) 1,2-Cyclohexylaminoarylamider til anvendelse som analgetika
BR0011042A (pt) Gel de silicone contendo ácido salicìlico
ATE383339T1 (de) Amin-derivate zur behandlung von apoptosis
NO941937L (no) Sakarinderivater som inhiberer proteolytiske enzymer
PT842934E (pt) Agonistas de 5-ht1f
DK0730493T3 (da) Anvendelse af et polymermateriale på basis af modificerede hydrokolloider som indkapslingsmateriale
DK0703232T3 (da) 2,3-Dihydro-1H-isoindolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som hæmmere af serotoningenoptagelsen
DK0709378T3 (da) Aminoalkyloximer, en fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og mellemproduktforbindelser
BR0114802A (pt) Trìmeros de n-alquilglicina capazes de bloquear a substáncias quìmicas, estìmulos térmicos ou mediadores da inflamação de receptores neuronais, e composições que os contêm
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
FI963055A (fi) Kondensaatio- ja additiopolymeereja, jotka sisältävät N,N'-sillan sisältäviä bis(tetrametyylipiperidinyylioksi)-ryhmiä
DK0534344T3 (da) Substituerede 3-amino-2,3,4,5-tetrahydro-1-aryl-oxy-3-benzazepiner, fremgangsmåde til deres fremstilling og deres anvendelse som modulatorer af neurotransmitterfunktionen
BR9900024A (pt) Biciclo[3.1.0]hexanos e compostos relacionados.
DE69503635D1 (de) Pyrrolidinderivate zur behandlung von cck und gastrin-abhängigen erkrankungen
DE69822009D1 (de) Indometacin Calciumsalz Pentahydrat und deren Herstellung